S.T.Stent
@ststent.com
S.T.Stent develops a composite removable sinus stent. The stent is designed to be placed into ethmoid sinus following functional endoscopic sinus surgery (FESS) to maintain the cavity open. FESS procedure is used to treat chronic sinusitis, which is one of the most common health problems in the modern world. However a single surgery often is not enough to cure the patient, due to post surgery scarring, stenosis and middle turbinate lateralization. The stent is designed to keep the cavity open, long enough for the healing process to complete itself and can be removed at any time, based on patient decision or physician consult. Stent removal is an in-office procedure, done without anesthesia, and is minimally invasive for the patient.
S.T.Stent's Company Logos
S.T.Stent's Brand Colors
Hex Code
Color name
RGB
HSL
CMYK
#13A89E
Mountain Meadow
19, 168, 158
176, 80, 37
89, 0, 6, 34
#7DB7F0
Jordy Blue
125, 183, 240
210, 79, 72
48, 24, 0, 6
#020202
Black
2, 2, 2
0, 0, 1
0, 0, 0, 99
About S.T.Stent
S. T. Stent is a pioneering brand in the medical device industry that specializes in the development of stents.
Founded in 2013, S. T. Stent operates within Trendlines Medical, a prestigious business incubator that is part of The Trendlines Group.
Headed by a team of exceptional individuals, including CEO Joseph Flomenblit, a renowned international expert in nitinol alloy with over 25 years of stent development experience, S. T. Stent has established itself as a leader in the field.
With a focus on innovative problem-solving, S. T. Stent offers a range of cutting-edge stent products.
Their expertise extends to working with global healthcare players, and they collaborate on international projects. The team's impressive track record includes a portfolio of over 60 patents and partnerships with industry giants such as Boston Scientific, J&J, Stryker, Velocimed, and Rafael. Under the guidance of esteemed scientific advisors, including Prof.
Gady Har-El and Prof. Eitan Yaniv, S. T.
Stent continues to revolutionize the industry. Their commitment to strategic and business development is further enhanced by the expertise of Chas McKhann, a seasoned professional who has spearheaded corporate strategy and business development for leading companies. With support from the European Union's Horizon 2020 program, S.
T. Stent remains at the forefront of medical device innovation. Delivering exceptional quality and services, S.
T. Stent is a trusted provider in the field of stent development and is dedicated to advancing healthcare
Company type
Privately Held
Year founded
2013
Company size
2-10 employees
